Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Sobi Canada Inc

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Sobi Canada Inc

arrow
Peptide Process CMC
Not Confirmed

Sobi Canada Inc

Country
arrow
Peptide Process CMC
Not Confirmed

Pegcetacoplan

Brand Name : EMPAVELI

Patent Number : 2835627

Filing Date : 2012-05-11

Strength per Unit : 54mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2032-05-11

Date Granted : 2023-01-10

blank